Lv11
38 积分 2025-06-18 加入
Fine tuning towards the next generation of engineered T cells
5小时前
已完结
Autologous CD7 CAR T cells generated without T-cell pre-selection in pediatric patients with relapsed/refractory T-ALL: a phase I trial
4天前
已完结
Preclinical development and a phase I trial of IMC001, an EpCAM-targeted CAR-T cell therapy, in patients with advanced gastric cancer
5天前
已完结
Triple knockdown of CD11a , CD49d , and PSGL1 in T cells reduces CAR-T cell toxicity but preserves activity against solid tumors in mice
5天前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
3个月前
已完结
In vivo CAR engineering for immunotherapy
3个月前
已完结
Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy
4个月前
已完结
Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy
4个月前
已关闭
Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy
4个月前
已完结
皖公网安备34019202002308
